DE69211258T2 - (R)-3-Methoxy-4-(1-Methyl)-5-(2-Methyl-4,4,4-Trifluorbutylcarbamoyl)Indol-3-Ylmethyl)-N-(2-Methylsulfonyl)-Benzamid in kristalliner Form - Google Patents

(R)-3-Methoxy-4-(1-Methyl)-5-(2-Methyl-4,4,4-Trifluorbutylcarbamoyl)Indol-3-Ylmethyl)-N-(2-Methylsulfonyl)-Benzamid in kristalliner Form

Info

Publication number
DE69211258T2
DE69211258T2 DE69211258T DE69211258T DE69211258T2 DE 69211258 T2 DE69211258 T2 DE 69211258T2 DE 69211258 T DE69211258 T DE 69211258T DE 69211258 T DE69211258 T DE 69211258T DE 69211258 T2 DE69211258 T2 DE 69211258T2
Authority
DE
Germany
Prior art keywords
methyl
trifluorobutylcarbamoyl
ylmethyl
methoxy
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69211258T
Other languages
English (en)
Other versions
DE69211258D1 (de
Inventor
Murray Watson Cuthbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of DE69211258D1 publication Critical patent/DE69211258D1/de
Publication of DE69211258T2 publication Critical patent/DE69211258T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE69211258T 1991-09-05 1992-09-01 (R)-3-Methoxy-4-(1-Methyl)-5-(2-Methyl-4,4,4-Trifluorbutylcarbamoyl)Indol-3-Ylmethyl)-N-(2-Methylsulfonyl)-Benzamid in kristalliner Form Expired - Lifetime DE69211258T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (2)

Publication Number Publication Date
DE69211258D1 DE69211258D1 (de) 1996-07-11
DE69211258T2 true DE69211258T2 (de) 1996-10-02

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69211258T Expired - Lifetime DE69211258T2 (de) 1991-09-05 1992-09-01 (R)-3-Methoxy-4-(1-Methyl)-5-(2-Methyl-4,4,4-Trifluorbutylcarbamoyl)Indol-3-Ylmethyl)-N-(2-Methylsulfonyl)-Benzamid in kristalliner Form

Country Status (21)

Country Link
US (2) US5352694A (de)
EP (1) EP0531078B1 (de)
JP (1) JP2914414B2 (de)
KR (1) KR100254710B1 (de)
AT (1) ATE138910T1 (de)
AU (1) AU646587B2 (de)
CA (1) CA2076722A1 (de)
CZ (1) CZ281999B6 (de)
DE (1) DE69211258T2 (de)
DK (1) DK0531078T3 (de)
FI (1) FI102372B (de)
GB (2) GB9119001D0 (de)
HK (1) HK18297A (de)
HU (2) HU213410B (de)
IL (1) IL102856A (de)
NO (1) NO178370C (de)
NZ (1) NZ244016A (de)
RU (1) RU2095348C1 (de)
SK (1) SK267092A3 (de)
TW (1) TW302359B (de)
ZA (1) ZA926374B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20080206203A1 (en) 2004-07-14 2008-08-28 Inflammation Research Center Company Ltd. Method for Inhibiting Tumor Metastasis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
KR930005976A (ko) 1993-04-20
ATE138910T1 (de) 1996-06-15
JPH05194385A (ja) 1993-08-03
FI102372B1 (fi) 1998-11-30
KR100254710B1 (ko) 2000-05-01
HU9202660D0 (en) 1992-10-28
CZ281999B6 (cs) 1997-04-16
CA2076722A1 (en) 1993-03-06
HU213410B (en) 1997-06-30
EP0531078A1 (de) 1993-03-10
FI923869A0 (fi) 1992-08-28
IL102856A (en) 1996-12-05
IL102856A0 (en) 1993-01-31
HUT69696A (en) 1995-09-28
NZ244016A (en) 1995-01-27
FI923869A (fi) 1993-03-06
HU210879A9 (en) 1995-09-28
GB9119001D0 (en) 1991-10-23
DK0531078T3 (da) 1996-10-14
HK18297A (en) 1997-02-13
US5466826A (en) 1995-11-14
SK279657B6 (sk) 1999-02-11
AU2101292A (en) 1993-03-11
NO178370B (no) 1995-12-04
JP2914414B2 (ja) 1999-06-28
EP0531078B1 (de) 1996-06-05
AU646587B2 (en) 1994-02-24
NO923467L (no) 1993-03-08
TW302359B (de) 1997-04-11
GB9216774D0 (en) 1992-09-23
NO178370C (no) 1996-03-13
SK267092A3 (en) 1999-02-11
US5352694A (en) 1994-10-04
FI102372B (fi) 1998-11-30
DE69211258D1 (de) 1996-07-11
CZ267092A3 (en) 1993-03-17
NO923467D0 (no) 1992-09-04
ZA926374B (en) 1993-03-05
RU2095348C1 (ru) 1997-11-10

Similar Documents

Publication Publication Date Title
IL167168A (en) Indoline compound in crystalline form for use in oral solid medicament and such oral solid medicament for treating dysuria
NZ242104A (en) Amides of aminoethylsubstituted benzothiazole, -thiazine, -oxazole and -oxazine derivatives; pharmaceutical compositions thereof
MY108629A (en) Heterocyclic compounds
DK0600371T3 (da) Guanidinalkyl-1,1-bisphosphonsyrederivater, fremgangsmåde til deres fremstilling samt deres anvendelse
BG104606A (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
NO912511L (no) Fremgangsmaate for forhindring eller begrensning av reperfusjonsskade
DE69211258D1 (de) (R)-3-Methoxy-4-(1-Methyl)-5-(2-Methyl-4,4,4-Trifluorbutylcarbamoyl)Indol-3-Ylmethyl)-N-(2-Methylsulfonyl)-Benzamid in kristalliner Form
KR960009422B1 (en) 4-(ardylamino)piperidinebutanamide derivatives
NZ515164A (en) Thiazolidinedione derivative and its use as antidiabetic
GR3021399T3 (en) Methanoanthracenes as dopamine antagonists
IL87197A0 (en) Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same
ES2062940A1 (es) Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
CA2622808C (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
PT100507A (pt) Nova forma fisica de derivados de amidas heterociclicos, processo para a sua preparacao e composicoes farmaceuticas que os contem
TH54864B (th) อนุพันธ์ไธอะโซลิดีนไดโอน และการใช้สารนี้เป็นยารักษาโรคเบาหวาน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTRAZENECA UK LTD., LONDON, GB